Loading patent…
AssigneesUniversite de Versailles Saint-Quentin-en-Yvelines, Centre National De La Recherche Scientifique, Bureau D’éTudes Biologiques Scientifiques Et MéDicales
InventorsJacques Henri Max COHEN, Clémence SICARD, Effrosyni GKANIATSOU
Estimating the term…
An immunogenic composition containing at least one antigen and at least one adjuvant including at least one Metal-Organic Framework including an inorganic part based on aluminum and an organic part based on polydentate ligand chosen from fumarate, muconate, mesaconate, oxalate, oxaloacetate, succinate, malate, citrate, aconitate, isophthalate, substituted isophthalate, 2,5-thiophenedicarboxylate, 2,5-furandicarboxylate, trimesate, trimellitate and pyromellitate, the antigen being immobilized at least within the Metal-Organic Framework.
An immunogenic composition containing at least one antigen and at least one adjuvant with:
A Metal-Organic Framework comprising an inorganic part based on aluminum and an organic part based on polydentate ligand chosen from fumarate, muconate, mesaconate, oxalate, oxaloacetate, succinate, malate, citrate, aconitate, isophthalate, substituted isophthalate, 2,5-thiophenedicarboxylate, 2,5-furandicarboxylate, trimesate, trimellitate and pyromellitate, for use to immobilize an antigen, in a vaccine adjuvant, said antigen being immobilized at least within said Metal-Organic Framework.
11-13. (canceled)
Dependencies are inferred from the claim text.